
    
      The study will be a blinded (investigators and outcome assessors), randomized (from parent
      study Akili-001R), parallel group, follow-up study of the sustained effects of 4-weeks of
      treatment with either AKL-T01 (EVO Multi) game-based digital therapy or AKL-T09 (EVO Words)
      game-based digital therapy.

      The trial will consist of 4 visits: Screening (to be conducted at the same time as the
      end-of-study visit for the parent study Akili-001R), FU-Day 28 visit (conducted in clinic),
      and FU-Day 56 and FU-Day 84 visits (conducted remotely via electronically captured parent
      reported outcomes).
    
  